Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression

Archives of Ophthalmology

Volumn 114, Issue 7, 1996, Pages 821-827

  Hoover, Donald R ^a,h   Peng, Yun ^a   Saah, Alfred ^a,f   Semba, Richard ^b   Detels, Roger R ^c   Rinaldo Jr , Charles R ^d,g   Phair, John P ^e  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF PITTSBURGH   (United States)

^h Hampton House ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL COUNT; CLINICAL TRIAL; COHORT ANALYSIS; CYTOMEGALOVIRUS; DISEASE ACTIVITY; HELPER CELL; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PNEUMOCYSTIS PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PROPHYLAXIS; RETINITIS; TREATMENT PLANNING;

EID: 0029946744     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1996.01100140035004     Document Type: Article

References (27)

1. Jacobson MA, Mills D. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1988;108:585-594.
2. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE, and the Zidovudine Epidemiology Study Group. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis. 1992;166:1223-1227.
3. Jabs DA, Green WR, Fox R, Polk BF, Bartlett JG. Ocular manifestations of acquired immunodeficiency syndrome. Ophthalmology. 1989;96:1092-1099.
4. Palestine AG, Polis MA, De Smet MD, et al. A randomized controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med. 1991;115:665-673.
5. Holland GN, Buhles NC Jr, Mastre B. A controlled trial of ganciclovir treatment for cytomegalovirus retinopathy use of a standardized system for assessment of disease outcome. Arch Ophthalmol. 1989;107:1759-1766.
6. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med. 1992;326:213-220.
7. Gallant JE, Moore RO, Chaisson RE. Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med. 1994;120:931-944.
8. Quinn TC, Plot P, McCormick JB, et al. Serologic and immunologic studies in patients with AIDS in North America and Africa: the potential role of infectious agents as cofactors in human immunodeficiency virus infection. JAMA. 1987; 257:2617-2621.
9. Sullivan JL, Brewster FE, Brettler DB, et al. Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate LAV/HTLV-III and herpes virus. J Pediatr. 1986;108:504-510.
10. Ouinnan GV, Masur H, Rook AH, et al. Herpes virus infections in the acquired immune deficiency syndrome. JAMA. 1984;252:72-77.
11. Collier AC, Meyers JD, Corey L, Murphy VL, Roberts PL, Handsfield HH. Cytomegalovirus infection in homosexual men: relationship to sexual practices, antibody to human immunodeficiency virus and cell-mediated immunity. Am J Med. 1987;82:593-601.
12. Drew WL, Mint L, Miner RC, Sands M, Ketterer B. Prevalence of cytomegalovirus infection in homosexual men. J Infect Dis. 1981;143:188-192.
13. Rinaldo CR Jr, Kingsley LA, Ho M, Armstrong JA, Zhou S, Enhanced shedding of cytomegalovirus in semen of human immunodeficiency virus-seropositive homosexual men. J Clin Microbiol. 1992;30:1148-1155.
14. Rinaldo CR Jr. Cytomegalovirus as a cofactor in HIV infection and AIDS. In: Watson RR, ed. Cofactors in HIV-1 Infection and AIDS. Boca Raton, Fla: CRC Press Inc; 1989;151-185.
15. Hoover DR, Saah AJ, Bacellar H, et al. Clinical manifestations of AIDS in the era of Pneumocystis carinii prophylaxis. N Engl J Med. 1993;329:1922-1926.
16. Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr Hum Retrovirol. 1991;4:771-776.
17. + lymphocyte counts at AIDS manifestations in Germany from 1986 to 1991. AIDS. 1992; 6:413-420.
18. Pertel P, Hirschtick R, Phair J, Chmiel J, Poggensee L, Murphy R. Risk of developing cytomegalovirus retinitis in persons infected with human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol. 1992;5: 1069-1074.
19. Luckie A, Ai E. Diagnosis and management of cytomegalovirus retinitis in AIDS. Curr Opin Ophthalmol. 1993;4:81-89.
20. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR Jr. The Multicenter AIDS Cohort Study: rationale, organization and selected characteristics of the participants. Am J Epidemiol. 1987;126:310-318.
21. Centers for Disease Control. Update acquired immunodeficiency syndrome - United States. MMWR Morbid Mortal Wkly Rep. 1987;32:245-248.
22. + counts and prevalence of cytomegalovirus and human immunodeficiency virus-related noninfectious renal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993;115:575-582.
23. + t-lymphocyte counts. N Engl J Med. 1995;333:670.
24. Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR Morbid Mortal Wkly Rep. 1989;38(suppl 5):1-9.
25. Aalen O. Nonparametric estimation of partial transition probabilities in multiple decrement models. Ann Stat. 1978;6:534-545.
26. Anderson PK, Borgain O, Gill RD, Keiding N. Statistical Methods Based on Counting Processes. New York, NY: Springer-Verlag NY Inc; 1994.
27. Hoover DR, Peng Y, Saah AJ, Detels RR, Rinaldo CR, Phair JP. Projecting disease when death is likely. Am J Epidemiol. 1996;143:943-952.